Litigation Details for EX PARTE APPLICATION OF SANDOZ CANADA INC. (D.N.J. 2020)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2020-03-05
Court	District Court, D. New Jersey	Date Terminated	2020-10-13
Cause	28:1782 Letter rogatory - appointment	Assigned To	Michael Andre Shipp
Jury Demand	None	Referred To	Douglas Arpert
Patents	7,767,225; 7,988,994; 8,383,150; 8,753,679
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2020-03-04	1	Exhibit 6	. 7,767,225, 7,988,994, 8,383,150, 8,753,679, Publication No. US 2014/242159, European Patent No. EP …’013 Patents, or corresponding foreign patents and applications, including United States Patent Nos. …. 2. The term “’380 Patent” refers to Canadian Patent No. 2,620,380, entitled “Capsule …” 3. The term “’013 Patent” refers to Canadian Patent No. 2,762,013, entitled “Granulation…clinical studies described in the ’380 and ’013 Patents.	External link to document
2020-09-22	3	Opinion AND Memorandum	. US 7,767,225, US 7,988,994, US 8,383,150, US 8,753,679 and Application Publication No. US 2014/242159…. I-I.) The Patents in Issue are 2,620,380 (°°380 Patent’) and 2,762,013 ("013 Patent”). (/d.) “Each… ‘013 Patents, or corresponding foreign patents and applications, including United States Patent Nos. …collectively, “Roche”) and Sandoz are engaged in several patent litigations in the Federal Court of Canada. (Pet…“Each of the Patents in Issue name three inventors: Ronald Vladyka, Ramachandran Radhakrishnan, and Kenneth	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document